New Law Suits
Novartis AG Prexige (lumiracoxib)
Australia's drugs watchdog had ordered the recall of the anti-inflammatory medication Prexige after it was linked to two deaths. Technically called lumiracoxib, Prexige is produced by the Switzerland-based company Novartis AG, which said it had contacted health authorities in 50 countries where the drug is sold about the withdrawal. The move followed a review of eight cases where people suffered severe liver damage after using the Prexige drug. Two of those people died and another two required liver transplants. Prexige is taken by about 60,000 people in Australia and is prescribed for osteoarthritis, post-operative pain, pain related to dental procedures and painful menstruation. The TGA has recommended people taking lumiracoxib seek an alternative medication and have liver function blood tests. Prexige is a non-steroidal anti-inflammatory drug, technically called a Cox-2 inhibitor. Another Cox-2 inhibitor, Vioxx or Rofecoxib, was voluntarily recalled by manufacturer Merck in 2004 due to adverse health conditions in patients taking it.
Novartis AG Prexige Legal Help
If you or a loved one has suffered liver damage in this Novartis AG lumiracoxib case, please click the link below to send your complaint to a lawyer who will evaluate your claim at no cost or obligation.
Click here for legal help and a free evaluation of your possible case
